Clinical Trial Update: Neoadjuvant FOLFOXIRI Versus CapeOX Chemotherapy for Local Advanced Rectal Cancer [Phase 3]

View source ↗

Summary

Phase 3 clinical trial comparing neoadjuvant FOLFOXIRI versus CapeOX chemotherapy for locally advanced rectal cancer is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rectal Cancer

Drugs mentioned

• CAPEOX
• FOLFOXIRI (folinic acid (leucovorin), fluorouracil (5-FU), oxaliplatin, irinotecan)

Snippet

Sponsor: Fudan University | Conditions: Rectal Cancer | Phase 3 | Status: RECRUITING